Off Patent
January 2027

Vibativ

telavancin hydrochloride

Apotex Inc

Powder (intravenous) · NDA 022110

Last listed protection ends
January 1, 2027

The FDA lists 1 patent for Vibativ, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,531,623
    Claims the drug substance